SecBot SecBot
SC 13G ·Filed Nov 19, 2026

ALXO

ALX ONCOLOGY HOLDINGS INC
NEUTRAL
Impact 4/10
Horizonimmediate Processed2d 12h ago SEC0001104659-26-130295
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future amendments that could indicate a shift from passive to active intent, or further accumulation. The stake is just above the 5% threshold, so the filing itself is routine.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Coastlands Capital LP disclosed a 5.34% passive stake in ALX Oncology Holdings Inc., holding 6,906,783 shares as of November 12, 2026. This is a new 13G filing (not an amendment) from a healthcare-focused investment firm, indicating a meaningful but passive position in the company.

Key Financial Metrics

Stake
5.34%
Investor
Coastlands Capital LP
Investor Type
hedge fund

Key Facts

  • Coastlands Capital LP filed a new Schedule 13G disclosing beneficial ownership of 6,906,783 shares of ALX Oncology Holdings Inc.
  • The stake represents 5.34% of the 129,274,568 shares outstanding as of November 9, 2026.
  • The shares are held directly by Coastlands Capital Partners LP, with Coastlands Capital LP as investment adviser.
  • The filing certifies passive intent under Rule 13d-1(b) and Rule 13d-1(c), with no purpose of changing or influencing control.
  • Matthew D. Perry is the control person of the reporting entities.

Financial Impact

6,906,783 shares, representing 5.34% of outstanding shares, valued at approximately $6.9M based on market cap of $130M.

ownership

Risk Factors

  • No risks identified from this passive stake filing.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (13 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0001104659-26-130295
Document: 0001104659-26-130295-index-headers.html0001104659-26-130295
Document: 0001104659-26-130295-index.html0001104659-26-130295
Document: 0001104659-26-130295.txt0001104659-26-130295

Track record

17 reports on ALXO

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +25.96% at T+20 after the May 8, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 19, 20262d ago SC 13G Neutral 4/10 Viewing Entry $0.9714 Now $1.06 +9.12% settles Nov 30
  2. Nov 16, 20265d ago Press Release Bearish 5/10 Entry $1.00 Now $1.06 −6.00% settles Nov 23
  3. Oct 16, 20265w ago SC 13D/A Neutral 4/10 Entry $1.14 to $1.13 Now $1.06 −7.02% ▼ −0.88% −0.73% vs SPY
  4. Oct 15, 20265w ago 8-K Mixed 6/10 Entry $1.06 to $1.17 Now $1.06 −0.00% ▲ +10.38% +10.81% vs SPY
  5. Sep 28, 20267w ago Press Release Mixed 5/10 Entry $1.39 to $1.21 Now $1.06 −23.74% ▼ −12.95% −14.15% vs SPY
  6. Aug 15, 202614w ago Institutional Cluster Neutral 4/10 Entry $1.97 to $1.99 Now $1.06 −46.19% ▲ +1.02% +2.21% vs SPY
  7. Aug 6, 202615w ago 8-K Neutral 4/10 Entry $2.11 to $1.94 Now $1.06 −49.76% ▼ −8.06% −9.27% vs SPY
  8. Jun 30, 202620w ago 8-K Neutral 3/10 Entry $2.06 to $2.36 Now $1.06 −48.54% ▲ +14.56% +14.30% vs SPY
  9. Jun 26, 202621w ago 8-K Neutral 5/10 Entry $2.20 to $2.19 Now $1.06 −51.82% ▼ −0.45% −1.84% vs SPY
  10. Jun 12, 202623w ago Institutional Cluster Bearish 5/10 Entry $1.58 to $1.53 Now $1.06 +32.91% ▲ +3.16% +3.84% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Mon (26h 28m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 19, 2026